Nkarta (NKTX) Change in Acquisitions & Divestments (2020 - 2026)
Nkarta's (NKTX) quarterly Change in Acquisitions & Divestments came in at $70.6 million in Q1 2026, down 6.4% year-on-year from $75.4 million in Q1 2025, and down 24.15% quarter-over-quarter from $93.1 million in Q4 2025.
Nkarta (NKTX) Change in Acquisitions & Divestments (2020 - 2026) Analysis & Trends
Nkarta's Change in Acquisitions & Divestments history runs 7 years deep, the most recent figure standing at $70.6 million for Q1 2026.
- On a quarterly basis, Change in Acquisitions & Divestments fell 6.4% year-over-year to $70.6 million in Q1 2026; TTM through Mar 2026 was $335.3 million, a 13.66% increase from a year earlier, with the FY2025 full-year figure at $340.1 million, up 20.93% from the prior year.
- Change in Acquisitions & Divestments slipped to $70.6 million in Q1 2026 per NKTX's latest filing, from $93.1 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $126.0 million in Q1 2023 and bottomed at $29.2 million in Q1 2022.
- The 5-year median for Change in Acquisitions & Divestments is $75.4 million (2025), against an average of $76.9 million.
- Across the five-year window, Change in Acquisitions & Divestments sank 53.69% in 2022 and surged 331.41% in 2023, its largest moves.
- Year by year, Change in Acquisitions & Divestments stood at $115.4 million in 2022, then slipped by 25.45% to $86.0 million in 2023, then retreated by 4.3% to $82.3 million in 2024, then climbed by 13.1% to $93.1 million in 2025, then slipped by 24.15% to $70.6 million in 2026.
- Per Business Quant, the three latest NKTX Change in Acquisitions & Divestments figures stand at $70.6 million (Q1 2026), $93.1 million (Q4 2025), and $83.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - |
| 2 | Nanobiotix | 1,924.26 Bn | 1,924.20 Bn | - |
| 3 | Akari Therapeutics | 975.59 Bn | 975.59 Bn | - |
| 4 | BeOne Medicines | 472.11 Bn | 467.32 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.89 Bn | 114.65 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.18 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.83 Bn | 62.83 Bn | - |
| 8 | Argenx Se | 55.82 Bn | 50.63 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.49 Bn | 37.49 Bn | - |
| 10 | Nkarta | 170.42 Mn | 170.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.61 Mn |
| Mar 31, 2026 | 70.61 Mn |
| Dec 31, 2025 | 93.08 Mn |
| Dec 31, 2025 | 93.08 Mn |
| Sep 30, 2025 | 83.16 Mn |
| Sep 30, 2025 | 83.16 Mn |
| Jun 30, 2025 | 88.42 Mn |
| Jun 30, 2025 | 88.42 Mn |
| Mar 31, 2025 | 75.44 Mn |
| Mar 31, 2025 | 75.44 Mn |
| Dec 31, 2024 | 82.30 Mn |
| Dec 31, 2024 | 82.30 Mn |
| Sep 30, 2024 | 68.23 Mn |
| Sep 30, 2024 | 68.23 Mn |
| Jun 30, 2024 | 69.00 Mn |
| Jun 30, 2024 | 69.00 Mn |
| Mar 31, 2024 | 61.70 Mn |
| Mar 31, 2024 | 61.70 Mn |
| Dec 31, 2023 | 86.00 Mn |
| Dec 31, 2023 | 86.00 Mn |